Angion Biomedica announces 1-for-10 reverse stock split
- Angion Biomedia (NASDAQ:ANGN) has announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10.
- Angion’s common stock will begin trading on a split-adjusted basis when the market opens on June 2, 2023 under the new trading symbol “ELTX.”
- The reverse stock split was previously approved by the stockholders to regain compliance with Nasdaq’s minimum bid price requirement of $1.00/share of common stock.
- ANGN +4.08% after hours to $1.02.